ALNYLAM PHARMACEUTICALS, INC. ($ALNY)
Filing Information
| Accession Number | 0001735276-26-000048 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 5, 2026 |
| Document | View SEC Filing |
Transactions
13
Total Shares
161,814
Total Value
$2,227,698.49
P&L
+inf% (+$48,391,032.55)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Mar 2, 2026 | Grant/Award | 13,844 | $0.00 | $0.00 | 105,427 | Direct | โ | View Details | |
Director | Common Stock | โ | Mar 2, 2026 | Sale | 200 | $323.62 | $64,724.00 | 105,227 | Direct | โ | View Details | |
Director | Common Stock | โ | Mar 2, 2026 | Sale | 382 | $324.65 | $124,016.30 | 104,845 | Direct | โ | View Details | |
Director | Common Stock | โ | Mar 2, 2026 | Sale | 1,098 | $325.63 | $357,541.74 | 103,747 | Direct | โ | View Details | |
Director | Common Stock | โ | Mar 2, 2026 | Sale | 1,669 | $326.81 | $545,445.89 | 102,078 | Direct | โ | View Details | |
Director | Common Stock | โ | Mar 2, 2026 | Sale | 1,399 | $327.67 | $458,410.33 | 100,679 | Direct | โ | View Details | |
Director | Common Stock | โ | Mar 2, 2026 | Sale | 424 | $328.71 | $139,373.04 | 100,255 | Direct | โ | View Details | |
Director | Common Stock | โ | Mar 2, 2026 | Sale | 722 | $329.71 | $238,050.62 | 99,533 | Direct | โ | View Details | |
Director | Common Stock | โ | Mar 2, 2026 | Sale | 346 | $330.85 | $114,474.10 | 99,187 | Direct | โ | View Details | |
Director | Common Stock | โ | Mar 2, 2026 | Sale | 399 | $331.93 | $132,440.07 | 98,788 | Direct | โ | View Details | |
Director | Common Stock | โ | Mar 2, 2026 | Sale | 160 | $332.64 | $53,222.40 | 98,628 | Direct | โ | View Details | |
Director | Stock Option (right to buy) | Derivative | Mar 2, 2026 | Grant/Award | 30,425 | $0.00 | $0.00 | 30,425 | Direct | โ | View Details | |
Director | Stock Price Performance Stock Unit | Derivative | Mar 2, 2026 | Grant/Award | 110,746 | $0.00 | $0.00 | 110,746 | Direct | โ | View Details |